Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

A legfontosabb adatok

Hol
Cincinnati, San Francisco és Virginia Beach (Egyesült Államok)Mind a 3 helyszín megnézése

Helyszínek itt: Egyesült Államok

  • University of Cincinnati College of MedicineCincinnati, Egyesült ÁllamokContact: Joseph BroderickRésztvevőt keres
  • University of CaliforniaSan Francisco, Egyesült ÁllamokContact: Nerissa KoRésztvevőt keres
  • University of VirginiaVirginia Beach, Egyesült ÁllamokContact: Bradford WorrallRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
University Hospital, Geneva
Azonosító
NCT05526352
A regiszteradat frissítve
2026. január 16.
Eredeti leírás
The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA).A teljes eredeti leírásKevesebb

@neurIST : Informatique biomédicale intégrée Pour la Gestion Des anévrismes cérébraux

The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA).

The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database.

The purpose for populating the database are to:

* Screen for and evaluate markers of risk for intracranial aneurysm formation and aneurysm rupture. Are considered as markers the following: genetics factors, microbiota, environmental factors, congenital factors (ie: cerebrovascular anatomical variants), transcriptomics signature, proteomics signature,shape characteristics, haemodynamics characteristics. * Screen for and evaluate prognostic factors of outcome regarding different management strategies including watchful observation, microsurgical treatment, endovascular treatment or any combination thereof. * Implement and evaluate patient-specific management protocols integrating all available information. * Evaluate the impact of the database and use of tools to improve care, reduce costs, support knowledge discovery and promote new industrial developments.

Bevonási feltételek: able to provide consent or, in the event that a patient is incapable of providing consent, that a person is legally authorized to do so on behalf of the patient according to legal and ethical requirements of the country where the clinical centre is located; Patients:; must have an angiographically proven intracranial aneurysm (MRA< CTA< DSA accepted).The determination of SAH requires the presence of a subarachnoid haemorrhage be verified on CT or by lumbar puncture; MRA: Magnetic Resonance Angiography CTA: Computed Tomography Angiography DSA: Digital Subtracted Angiography.

Kizáró feltételek: failure of a candidate to contribute clinical data,; refusal to provide informed consent.

ClinicalTrials.gov NCT05526352